Glenmark Pharma to raise Rs 1413 crore via debt securities Medical Dialogues Bureau30 Sept 2019 3:03 PM ISTAccording to the proposal, Glenmark Pharma plans to raise up to $ 200 million in Indian and/or international market through bonds, debentures or other...
Mylan to infuse USD 1 billion on capex in India Medical Dialogues Bureau30 Sept 2019 9:30 AM ISTMylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million...
Biocon chief Kiran Shaw vows to cut cost of rh-Insulin Medical Dialogues Bureau29 Sept 2019 10:00 AM ISTNew Delhi: Biocon Chief, Kiran Mazumdar-Shaw, Philanthropist and Founder of Biocon, recently, announced her personal commitment towards enabling...
OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and healthcare innovation forum Medical Dialogues Bureau29 Sept 2019 9:57 AM ISTBangalore, : OncoStem Diagnostics, an Oncology focused company that enables personalised cancer treatment was named as 'Best Innovation- Cancer Risk...
Abbott neurostimulation system Proclaim XR gets USFDA nod for chronic pain Medical Dialogues Bureau29 Sept 2019 9:55 AM ISTProclaim XR is currently under review for CE Mark. It is the latest advancement from Abbott, featuring upgradeable software and consumer-friendly...
Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder Medical Dialogues Bureau28 Sept 2019 2:38 PM IST"Solifenacin Succinate Tablet is a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc, " Strides Pharma said.Bangalore:...
Eisai Pharma, Mylan sign agreement commercialize metastatic breast cancer drug TECERIS in India Medical Dialogues Bureau28 Sept 2019 9:57 AM ISTNew Delhi- Eisai Pharmaceuticals India Pvt. Ltd and Mylan Pharmaceuticals Pvt Ltd. (Mylan), jointly announced that they have entered into a marketing...
Zydus receives final approval from USFDA for Clobetasol Propionate Lotion Medical Dialogues Bureau28 Sept 2019 9:02 AM ISTNew Delhi: Zydus Cadila has received the final approval from the USFDA to market Clobetasol Propionate Lotion, (US RLD - Clobex Lotion),...
Cipla launches skin treatment Daptomycin Injection in US Medical Dialogues Bureau27 Sept 2019 1:53 PM ISTDrug firm Cipla on Wednesday said it has launched Daptomycin Injection, used for treating complicated skin infections, in the US market. Daptomycin...
Fraud: SEBI bars Morepen from market for 1 year Medical Dialogues Bureau27 Sept 2019 1:44 PM ISTNew Delhi: Capital markets regulator SEBI on Tuesday barred Morepen Laboratories from the capital markets for one year for making misleading...
AstraZeneca India bags DCGI marketing nod for QTERN-once-daily anti-diabetes drug Medical Dialogues Bureau27 Sept 2019 11:54 AM IST26 September 2019: AstraZeneca Pharma India Limited (AstraZeneca India) announced that it has received Import & Market permission for QTERN®...
Strides Pharma suspends sale of Ranitidine tab in US Medical Dialogues Bureau27 Sept 2019 9:56 AM ISTNew Delhi: Strides Pharma Science on Friday suspended the sale of Ranitidine tablets after it received an information request from the US health...
